Treatment did not influence CD79+/CD20-/CD21-/CD23-/CD5± IPC expression (Table 3) as IPCs were observed with similar frequency in treated and untreated patients, and there was no significant difference between the IBD subgroups (Table 3). Here, CD5 is linked to inflammatory bowel disease.